ALMS · Alumis Inc.
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| $7.4M | $24.05M | — | — | |
| $347.5M | $386M | $265.55M | $137.68M | |
| $77.08M | $91.86M | $35.2M | $20.5M | |
| $3.42M | $3.5M | $3.15M | $1.28M | |
| $466.4M | $477.85M | $300.75M | $158.17M | |
| -$459M | -$453.8M | -$300.75M | -$158.17M | |
| — | -1886.92% | — | — | |
| -$455.58M | -$450.31M | -$297.6M | -$156.89M | |
| $18.29M | $201.92M | $6.52M | $3.18M | |
| — | -$251.89M | -$294.23M | — | |
| — | -$8.56M | $0 | $0 | |
| -$438.96M | -$243.33M | -$294.23M | -$154.99M | |
| — | -1011.75% | — | — | |
| -$439.66M | -$243.18M | -$294.2M | -$154.86M | |
| USD/shares | -$3.67 | -$2.86 | -$10.38 | -$72.08 |
| USD/shares | -$3.66 | -$2.86 | -$10.38 | -$72.08 |
| shares | — | 85.03M | 28.34M | 2.15M |
| shares | — | 85.03M | 28.34M | 2.15M |
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2023–FY2025: $87K in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 231 similar-size Biotechnology companies (of 524 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 |
|---|---|
| Single Reportable Segment | $24,050,000 |
By Product & Service (USD)
| Component | FY2025 |
|---|---|
| License | $17,389,000 |
| Collaboration Revenue | $6,661,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Single Reportable Segment | -$453,804,000 | -$300,754,000 | -$158,174,000 |
Operating Margin by Segment (%)
| Component | FY2025 |
|---|---|
| Single Reportable Segment | -1886.9% |